ClinicalTrials.Veeva

Menu

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Adverse Event
Corona Virus Infection
COVID

Treatments

Other: EPIC risk score display

Study type

Observational

Funder types

Other

Identifiers

NCT04570488
PAU COVID19

Details and patient eligibility

About

Testing use of predictive analytics to predict which COVID-19+ patients are at low risk for an adverse event (ICU transfer, intubation, mortality, hospice discharge, re-presentation to the ED, oxygen requirements exceeding nasal cannula at 6L/Min) in the next 96 hours

Full description

To assess if display of low risk of adverse event in EPIC can safely reduce length of stay and plan for discharge.

Enrollment

1,415 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Adult hospitalized COVID19+ patients predicted to have no adverse event at 96 events with a threshold at 90% PPV, with at least one low risk during their admission who are discharged alive and have not been in the ICU

Exclusion Criteria: Age < 18 years not hospitalized for COVID19+.

Trial design

1,415 participants in 2 patient groups

Quality improvement - Display
Description:
Display of risk score/ colored flag in Epic patient list column; will be viewable to all frontline workers
Treatment:
Other: EPIC risk score display
No Display
Description:
No display ("hidden") of risk score/ colored flag in Epic patient list column; not viewable to all frontline workers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems